SK Chemicals Co.,Ltd

KSE 285130.KS

SK Chemicals Co.,Ltd Shareholders' Equity for the year ending December 31, 2023: USD 1.63 B

SK Chemicals Co.,Ltd Shareholders' Equity is USD 1.63 B for the year ending December 31, 2023, a -4.05% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.

SK Chemicals Co.,Ltd Shareholders' Equity for the year ending December 31, 2022 was USD 1.70 B, a -1.33% change year over year.
SK Chemicals Co.,Ltd Shareholders' Equity for the year ending December 31, 2021 was USD 1.72 B, a 96.49% change year over year.
SK Chemicals Co.,Ltd Shareholders' Equity for the year ending December 31, 2020 was USD 874.74 M, a 41.80% change year over year.
SK Chemicals Co.,Ltd Shareholders' Equity for the year ending December 31, 2019 was USD 616.87 M, a -0.26% change year over year.

Key data

Date	Shareholders' Equity	Minority Interest	Total Equity	Total Stockholders Equity and Liabilities

KSE: 285130.KS

SK Chemicals Co.,Ltd

CEO	Mr. JAEHYEON AHN
IPO Date	Jan. 10, 2018
Location	South Korea
Headquarters	310, Pangyo-ro
Employees	1,345
Sector	Materials
Industries Chemicals & Advanced Materials Petrochemicals Pharmaceuticals

Description

SK Chemicals Co., Ltd. provides chemicals and life sciences products and solutions in South Korea and internationally. The company develops copolysters, coating and adhesive materials, engineering plastics, prepergs, bio materials, and 3D printing materials, as well as specialty chemicals, pharmaceutical products, and vaccines. It has a collaborate agreement with Standigm, Inc. to develop an AI-driven drug candidate for non-alcoholic steatohepatitis. The company was founded in 1969 and is headquartered in Seongnam, South Korea.

Key trends

Past 5 years